Abivax

The sponsor demonstrates a concentrated focus on inflammatory bowel diseases, particularly ulcerative colitis. Research efforts encompass both moderate to severe ulcerative colitis and investigations into maintenance therapy for patients who have achieved clinical remission. The programme extends to understanding disease activity assessment and long-term management strategies for chronic intestinal inflammation.

• Ulcerative Colitis Treatment
• Maintenance of Remission
• Chronic Inflammatory Conditions

The research portfolio includes extensive evaluation of therapeutic interventions across diverse patient populations, with particular attention to those experiencing persistent disease activity despite conventional treatment approaches.